Effect of daclizumab beta versus intramuscular interferon beta-1a on 24 week sustained disability progression using a modified multiple sclerosis functional composite

Document Type

Presentation

Publication Date

2017

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences

This document is currently not available here.

Share

COinS